Dr. Issame Outaleb

Dr. Issame Outaleb is a highly skilled and experienced professional in the pharma and healthcare industry. He holds a Ph.D. from the Max Planck Institute of Immunobiology and Epigenetics, and he specializes in change management, digital transformation, market access, and innovation. He has years of expertise in the healthcare landscape assessment in the EU5 and USA, and he has worked on brand and portfolio strategy, key account planning, project management, market assessment, biosimilars landscaping, and more. Dr. Outaleb is also experienced in therapeutic areas, including oncology, cardiology, pulmonary, orphan/rare diseases, Alzheimer's, digestive health, and medical devices. He is the founder and CEO of PharmaTrace, and he has worked with companies such as GSK, Florio GmbH, IMS Consulting Group, and Campbell Alliance, among others.